Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: In vivo Study. A more efficient combination

Lung cancer is the leading cause of cancer death after prostate cancer for males and breast cancer for females. There are novel therapies in the past five years such as; tyrosine kinase inhibitors and most recently in the last two years immunotherapy. Immunotherapy is currently being investigated if...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapalidis, Konstantinos, Zarogoulidis, Paul, Pavlidis, Efstathios, Laskou, Stella, Katsaounis, Athanasios, Koulouris, Charilaos, Giannakidis, Dimitrios, Mantalovas, Stylianos, Huang, Haidong, Bai, Chong, Wen, Yuting, Wang, Li, Sardeli, Chrysanthi, Amaniti, Aikaterini, Karapantzos, Ilias, Karapantzou, Chrysanthi, Hohenforst-Schmidt, Wolfgang, Konstantinou, Fotis, Kesisoglou, Isaak, Benhassen, Naim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995940/
https://www.ncbi.nlm.nih.gov/pubmed/29896282
http://dx.doi.org/10.7150/jca.24782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995940/
https://www.ncbi.nlm.nih.gov/pubmed/29896282
http://dx.doi.org/10.7150/jca.24782

Ejemplares similares